Markets:

Overview

News

Currencies

International

Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

13.97 +0.04 (+0.29%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventyx Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗

Today 11:18 EST

Praxis Precision Medicines develops therapies for central nervous system disorders, with candidates targeting depression and epilepsy.

Via The Motley Fool

Topics Regulatory Compliance

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗

Today 11:07 EST

This clinical-stage biotech develops monoclonal antibody therapies targeting chronic inflammatory and immunological diseases.

Via The Motley Fool

Topics Regulatory Compliance

Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know. ↗

February 10, 2026

Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?

Via The Motley Fool

Topics Intellectual Property

Halper Sadeh LLC is Investigating Whether VAL, STKL, VTYX are Obtaining Fair Deals for their Shareholders

February 10, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX

February 05, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating STEL, CWBC, SKYT, VTYX on Behalf of Shareholders

February 05, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating STEL, CLBK, NFBK, VTYX on Behalf of Shareholders

February 03, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences

January 28, 2026

In a strategic move to solidify its dominance in the burgeoning field of oral anti-inflammatories, Eli Lilly and Company (NYSE:LLY) announced on January 7, 2026, a definitive agreement to acquire...

Via MarketMinute

Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 27, 2026

In a decisive move to solidify its leadership in the next generation of chronic inflammation and cardiometabolic treatments, Eli Lilly and Company (NYSE: LLY) announced the acquisition of Ventyx...

Via MarketMinute

Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

January 21, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc.

January 21, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗

January 17, 2026

The pharmaceutical leader has plenty of cash and is using it effectively.

Via The Motley Fool

Topics Intellectual Property

Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights

January 17, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

In a bold move to solidify its dominance in the cardiometabolic market, Eli Lilly and Company (NYSE:LLY) announced on January 7, 2026, that it has entered into a definitive agreement to acquire Ventyx...

Via MarketMinute

Topics Intellectual Property

Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights

January 14, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns ↗

January 13, 2026

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights

January 13, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX), Flushing Financial Corp. (Nasdaq - FFIC), FONAR Corporation (Nasdaq -

January 12, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 09, 2026

In a move that underscores the tightening intersection between metabolic health and systemic inflammation, Eli Lilly and Company (NYSE: LLY) officially announced on January 7, 2026, its definitive...

Via MarketMinute

On Friday, there are stocks with unusual volume. Let's take a look. ↗

January 09, 2026

Via Chartmill

VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders

January 08, 2026

From Halper Sadeh LLC

Via Business Wire

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗

January 08, 2026

Nvidia, Apple, Microsoft, and select biotech names dominated early market buzz.

Via Stocktwits

Topics ETFs Government Stocks

Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗

January 07, 2026

Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth.

Via Stocktwits

Topics Initial Public Offering

Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗

January 07, 2026

Lilly will acquire all of the outstanding shares of Ventyx for $14 per share of common stock in an all-cash transaction.

Via Stocktwits

Wednesday's pre-market session: top gainers and losers ↗

January 07, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗

January 07, 2026

Via Stocktwits

Topics Stocks

Tuesday's after hours session: top gainers and losers ↗

January 06, 2026

Via Chartmill

Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗

January 06, 2026

A deal for Ventyx could be announced imminently, the Wall Street Journal reported, citing people familiar with the matter.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.